Gene therapy linked to brain tumor in boy with genetic disorder
This digest was compiled by AI from multiple sources — links to the originals are below.
A boy who received life-saving gene therapy for a genetic disorder later developed a brain tumor, which genetic analysis linked to the virus used in the treatment. The case, reported in Nature on May 21, 2026, is a rare instance of cancer caused by a therapeutic virus. Researchers are investigating the mechanisms to improve future safety.
The Case
A child with a rare genetic disorder received gene therapy using a modified virus to deliver a corrective gene. Years later, the boy developed a brain tumor. Genetic sequencing revealed that the virus had integrated into the child's DNA near a cancer-related gene, potentially triggering tumor growth.
The Investigation
Researchers from multiple institutions conducted genomic analysis of the tumor tissue. They found the viral vector inserted near the proto-oncogene MYB, which is associated with certain cancers. The study, published in Nature on May 21, 2026, estimates the risk of such an event at less than 1 in 10,000 patients.
Implications for Gene Therapy
The finding underscores a known but rare risk of viral vector-based gene therapies. Regulatory agencies and developers are reviewing safety protocols. The boy is receiving treatment for the tumor, and his prognosis remains guarded.
Brain-delivered gene therapy approval
The first brain-delivered gene therapy for AADC deficiency was approved in Europe and the U.K. in 2023. The therapy delivers a corrective gene directly to the brain using a viral vector.
What's Next
Researchers plan to study the integration patterns of viral vectors in larger patient cohorts. It remains unclear whether this case will lead to changes in gene therapy protocols or informed consent procedures.
2 sources
Gene therapy linked to brain tumor in boy with genetic disorder
